Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ: BIIB )

268.17 USD +2.44 (+0.92%)
Official Closing Price Updated: 5:52 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen Idec

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
3 Biotech Stocks With Big Catalysts Around the Corner
Upcoming events could send these stocks screaming higher or lower. 
Tags BIIB NVAX JNJ
From Motley Fool
Week in Review: Sorrento Acquires ACEA in $488 Million Deal between Two San Diego-China Oncology Biopharmas
Deals and Financings   Sorrento Therapeutics will acquire ACEA Therapeutics in a deal worth up to $488 million; both companies are San Diego-China oncology biopharmas; Long Hill Capital, a  China... 
From ChinaBio® Today
Noteworthy Friday Option Activity: JNJ, BIIB, BBY
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Johnson & Johnson (JNJ), where a total of 33,855 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
There’s more money to be made in stocks than in ETFs today — here’s why
There’s wider-than-usual dispersion in the returns of individual stocks as the bull market matures. 
Tags BIIB SJM VOOG
From MarketWatch
Biotech Stocks Hit A Snag — Why Experts Say The Heyday Isn't Over
Regulatory and drug-pricing worries have knocked biotech stocks off their Covid-19 pedestal. After hitting a high point in early February, biotech stocks have collectedly fallen 21%. 
From Investor's Business Daily
Biotech Stocks Could Use A Win — Will The First Quarter Offer That?
Gilead Sciences, Biogen and Vertex Pharmaceuticals could top expectations in an otherwise soft quarter for biotech stocks, an analyst said Thursday. He sees key products beating forecasts. 
From Investor's Business Daily
Biogen, Bio-Thera Ink Licensing Agreement For Development Of Actemra-Based Biosimilar For Rheumatoid Arthritis
Biogen Inc(NASDAQ:BIIB) and Bio-Thera Solutions Ltd haveentered into a commercialization and license ... 
Tags rheumatoid arthritis General Phase 3 Trial
From Benzinga
Biogen Acquires Rights to Bio-Thera RA Biosimilar for $30 Million Upfront
Biogen, a Cambridge , MA biopharma, in-licensed ex-China rights to a biosimilar aimed at rheumatoid arthritis from Guangzhou 's Bio-Thera. The candidate, BAT1806, is a proposed biosimilar to Roche's... 
From ChinaBio® Today
Biogen Acquires Rights to Bio-Thera RA Biosimilar for $30 Million Upfront
Biogen, a Cambridge , MA biopharma, in-licensed ex-China rights to a biosimilar aimed at rheumatoid arthritis from Guangzhou 's Bio-Thera. The candidate, BAT1806, is a proposed biosimilar to Roche's... 
From ChinaBio® Today
Why Scholar Rock Shares Dropped Despite Positive Apitegromab Data In Spinal Muscular Atrophy
Scholar Rock(NASDAQ:SRRK) shares dropped despite the companyreporting positive 12-month dataon spinal ... 
Tags IONS Market News Spinal Muscular Atrophy
From Benzinga
Is This Another Strike Against Biogen's Alzheimer's Drug?
Experts worry about how trial data was analyzed. 
Tags BIIB Market News
From Motley Fool
Pharma and Biotech Stocks On Sale
Healthcare represents a fertile field for value-oriented investors seeking good investments that simultaneously provide a margin of safety. 
Tags Stocks / Equities Healthcare Pharma/Biotech
From Blogs - TalkMarkets
2 Surefire Stocks to Buy for a Biden Bull Market
These two healthcare stocks could be big winners in a post-pandemic economy. 
Tags LLY SNY NVAX
From Motley Fool
Top Health Care Stocks Worth Investing In Now? 4 In Focus
Tags Market News
From StockMarket.com
Two Things That Could Stoke Biogen Stock — That Aren't Aducanumab
Biogen's future isn't only wrapped up in Alzheimer's treatment aducanumab, an analyst said Thursday. He identified two low-probability events that could stoke Biogen stock. BIIB stock rose. 
From Investor's Business Daily
3 Top Biotech Stocks for Spring 2021
Though these stocks have dropped, upcoming news offers hope for them to rebound. 
Tags GILD BIIB SAGE
From Motley Fool
Will Another Alzheimer's Disease Drug Bite the Dust After Lilly's Latest Results?
Investors aren't optimistic after Eli Lilly reported mixed results from a phase 2 study of its Alzheimer's disease candidate, donanemab. 
Tags LLY Market News BIIB
From Motley Fool
Notable Monday Option Activity: JBHT, BIIB, KSU
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in J. . 
Tags Stocks
From Market News Video
Looking For The Top Biotech Stocks To Watch This Week? 4 To Watch
Tags Market News
From StockMarket.com
Got $5,000? Consider These 3 Leading Pharma Stocks
They're making headway into tomorrow's hot markets. 
Tags REGN PFE BNTX
From Motley Fool
Should You Buy Cassava Sciences Stock Now?
A potential new treatment for Alzheimer's disease could be worth billions. 
Tags JNJ LLY SAVA
From Motley Fool
3 Reasons to Buy Sage Therapeutics, and 1 Reason to Pass
Can this brain health-focused biotech continue to rise, or will it fade -- again? 
Tags C Market News BIIB
From Motley Fool
The age of the ‘silver stoners’ is nigh
This is your brain on CBD 
Tags SAVA LLY BIIB
From MarketWatch
Before You Buy Biogen, Stop and Consider These 3 Things
They'll determine short-term and long-term stock performance. 
Tags DNLI RHHBY BIIB
From Motley Fool
Why Eli Lilly's Successful Alzheimer's Disease Study Was So Disappointing
Eli Lilly's latest Alzheimer's disease candidate is a terrific success and a disappointing flop at the same time. 
Tags LLY BIIB Market News
From Motley Fool
Why Denali Therapeutics Stock Popped Today
The biotech received good news from the FDA concerning one of its pipeline candidates. 
Tags DNLI Market News BIIB
From Motley Fool
Portfolio Hi-Lites: March 2021
During the past three months, the S&P 500 index rose 7.1% as vaccines started rolling out and investors looked forward to a more “normal” 2021. The following HI quality stocks generated 10% or better... 
Tags Pharma/Biotech Stocks / Equities Technology
From Blogs - TalkMarkets
Notable Wednesday Option Activity: DORM, BIIB, FREQ
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Dorman Products Inc (DORM), where a total volume of 870 contracts has been traded... 
Tags Stocks
From Market News Video
4 Stocks To Buy Ready To Bounce Back From 2020’s Dumpster Fire
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>These 4 stocks to buy have good fundamentals, are attractive from a... 
Tags BIIB TM Market News
From InvestorPlace
3 Healthcare Companies Worth a Look
Swinging for the fences. 
Tags MSFT ABBV AZN
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.